Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

884
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
884
Disorders of Leukocytes01:27

Disorders of Leukocytes

823
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
823
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.6K
Overview
66.6K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

10.7K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.7K
Humoral Immune Responses01:36

Humoral Immune Responses

71.1K
Overview
71.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.

The Lancet. Haematology·2026
Same author

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma.

Blood advances·2026
Same author

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.

Blood advances·2026
Same author

A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal of medical economics·2025
Same author

Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2025

相关实验视频

Updated: May 22, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

20.9K

免疫功能障碍和慢性淋巴细胞白血病的后果

Mayur Narkhede1, Chaitra S Ujjani2

  • 1O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL.

Journal of the National Comprehensive Cancer Network : JNCCN
|March 12, 2025
PubMed
概括

传染性并发症是慢性淋巴细胞白血病 (CLL) 的主要死亡原因. 新的CLL治疗可能会增加因感染而导致的死亡,强调需要改善患者的免疫功能.

科学领域:

  • 血液学 血液学 血液学
  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.

背景情况:

  • 传染性并发症是慢性淋巴细胞白血病 (CLL) 死亡的主要原因.
  • 布鲁顿氨酸激酶抑制剂和BCL-2抑制剂的进展改善了CLL治疗结果.
  • 预计CLL进展死亡率的下降可能会导致感染相关死亡人数增加.

研究的目的:

  • 审查CLL患者的免疫功能障碍.
  • 讨论这些免疫缺陷的临床后果和治疗影响.
  • 总结目前用于增强CLL免疫功能的策略.

主要方法:

  • 对CLL免疫功能障碍现有数据的文献综述.
  • 临床后果和治疗策略的分析.
  • 关于CLL患者免疫系统增强的信息综合.

主要成果:

  • 这种类型的CLL与显著的免疫功能障碍有关.
  • 这些免疫缺陷具有严重的临床后果,包括增加对感染的易感性.
  • 目前的治疗进展需要专注于管理感染风险.

结论:

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.0K

相关实验视频

Last Updated: May 22, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

20.9K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.7K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.0K
  • 了解CLL相关的免疫缺陷对于患者的生存至关重要.
  • 需要增强受损免疫系统的策略来补充新的CLL疗法.
  • 对免疫增强的进一步研究对于改善CLL的结果至关重要.